HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by Allianz SE

Allianz SE grew its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 59.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,389 shares of the company's stock after purchasing an additional 2,009 shares during the quarter. Allianz SE's holdings in HCA Healthcare were worth $1,862,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the stock. Avantax Advisory Services Inc. boosted its holdings in HCA Healthcare by 0.4% in the 1st quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock valued at $2,791,000 after purchasing an additional 32 shares in the last quarter. Catalyst Financial Partners LLC boosted its stake in shares of HCA Healthcare by 4.3% in the first quarter. Catalyst Financial Partners LLC now owns 872 shares of the company's stock valued at $301,000 after buying an additional 36 shares in the last quarter. Moors & Cabot Inc. raised its position in HCA Healthcare by 4.8% in the first quarter. Moors & Cabot Inc. now owns 858 shares of the company's stock worth $297,000 after acquiring an additional 39 shares in the last quarter. Perigon Wealth Management LLC grew its stake in shares of HCA Healthcare by 2.3% during the 1st quarter. Perigon Wealth Management LLC now owns 1,797 shares of the company's stock worth $621,000 after purchasing an additional 40 shares during the period. Finally, Barden Capital Management Inc. lifted its stake in shares of HCA Healthcare by 1.4% in the first quarter. Barden Capital Management Inc. now owns 2,921 shares of the company's stock valued at $1,009,000 after purchasing an additional 41 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

HCA opened at $356.84 on Monday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The stock has a market capitalization of $85.84 billion, a PE ratio of 15.00, a P/E/G ratio of 1.12 and a beta of 1.39. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company's 50 day simple moving average is $370.66 and its 200 day simple moving average is $347.68.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The business had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same period last year, the company posted $5.50 EPS. The business's quarterly revenue was up 6.4% on a year-over-year basis. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a $0.72 dividend. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.8%. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.

Insider Transactions at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer directly owned 12,646 shares in the company, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.30% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. Robert W. Baird reaffirmed a "neutral" rating and issued a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Wolfe Research cut HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. Baird R W cut shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Finally, Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Nine analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, HCA Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $396.46.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.